Danaher Common Stock Net 2010-2025 | DHR
Danaher common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.
- Danaher common stock net for the quarter ending June 30, 2025 was $9M, a 0% increase year-over-year.
- Danaher common stock net for 2024 was $0.009B, a 0% decline from 2023.
- Danaher common stock net for 2023 was $0.009B, a 0% decline from 2022.
- Danaher common stock net for 2022 was $0.009B, a 0% decline from 2021.
| Danaher Annual Common Stock Net (Millions of US $) |
|
|---|---|
| 2024 | $9 |
| 2023 | $9 |
| 2022 | $9 |
| 2021 | $9 |
| 2020 | $9 |
| 2019 | $8 |
| 2018 | $8 |
| 2017 | $8 |
| 2016 | $8 |
| 2015 | $8 |
| 2014 | $8 |
| 2013 | $8 |
| 2012 | $8 |
| 2011 | $8 |
| 2010 | $7 |
| 2009 | $4 |
| Danaher Quarterly Common Stock Net (Millions of US $) |
|
|---|---|
| 2025-06-30 | $9 |
| 2025-03-31 | $9 |
| 2024-12-31 | $9 |
| 2024-09-30 | $9 |
| 2024-06-30 | $9 |
| 2024-03-31 | $9 |
| 2023-12-31 | $9 |
| 2023-09-30 | $9 |
| 2023-06-30 | $9 |
| 2023-03-31 | $9 |
| 2022-12-31 | $9 |
| 2022-09-30 | $9 |
| 2022-06-30 | $9 |
| 2022-03-31 | $9 |
| 2021-12-31 | $9 |
| 2021-09-30 | $9 |
| 2021-06-30 | $9 |
| 2021-03-31 | $9 |
| 2020-12-31 | $9 |
| 2020-09-30 | $9 |
| 2020-06-30 | $9 |
| 2020-03-31 | $8 |
| 2019-12-31 | $8 |
| 2019-09-30 | $8 |
| 2019-06-30 | $8 |
| 2019-03-31 | $8 |
| 2018-12-31 | $8 |
| 2018-09-30 | $8 |
| 2018-06-30 | $8 |
| 2018-03-31 | $8 |
| 2017-12-31 | $8 |
| 2017-09-30 | $8 |
| 2017-06-30 | $8 |
| 2017-03-31 | $8 |
| 2016-12-31 | $8 |
| 2016-09-30 | $8 |
| 2016-06-30 | $8 |
| 2016-03-31 | $8 |
| 2015-12-31 | $8 |
| 2015-09-30 | $8 |
| 2015-06-30 | $8 |
| 2015-03-31 | $8 |
| 2014-12-31 | $8 |
| 2014-09-30 | $8 |
| 2014-06-30 | $8 |
| 2014-03-31 | $8 |
| 2013-12-31 | $8 |
| 2013-09-30 | $8 |
| 2013-06-30 | $8 |
| 2013-03-31 | $8 |
| 2012-12-31 | $8 |
| 2012-09-30 | $8 |
| 2012-06-30 | $8 |
| 2012-03-31 | $8 |
| 2011-12-31 | $8 |
| 2011-09-30 | $8 |
| 2011-06-30 | $8 |
| 2011-03-31 | $7 |
| 2010-12-31 | $7 |
| 2010-09-30 | $7 |
| 2010-06-30 | $7 |
| 2010-03-31 | $4 |
| 2009-12-31 | $4 |
| 2009-09-30 | $4 |
| 2009-06-30 | $4 |
| 2009-03-31 | $4 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $147.686B | $23.875B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS Health (CVS) | United States | $90.749B | 11.28 |
| Elevance Health (ELV) | United States | $69.812B | 9.39 |
| Cencora (COR) | United States | $56.166B | 18.70 |
| DiDi Global (DIDIY) | China | $27.862B | 29.60 |
| Labcorp Holdings (LH) | United States | $23.139B | 18.39 |
| Natera (NTRA) | United States | $22.743B | 0.00 |
| BioMerieux (BMXMF) | France | $17.423B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.474B | 0.00 |
| ICON (ICLR) | Ireland | $13.871B | 13.35 |
| Medpace Holdings (MEDP) | United States | $13.184B | 34.89 |
| CochLear (CHEOY) | Australia | $12.924B | 0.00 |
| Solventum (SOLV) | United States | $12.643B | 13.05 |
| Viatris (VTRS) | United States | $12.137B | 4.32 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.796B | 0.00 |
| Revvity (RVTY) | United States | $10.589B | 18.66 |
| Avantor (AVTR) | United States | $9.067B | 13.30 |
| Charles River Laboratories (CRL) | United States | $8.057B | 15.29 |
| Sonic Healthcare (SKHHY) | Australia | $7.725B | 0.00 |
| HealthEquity (HQY) | United States | $7.725B | 33.84 |
| Bausch + Lomb (BLCO) | Canada | $5.112B | 34.38 |
| Sotera Health (SHC) | United States | $4.658B | 26.03 |
| BrightSpring Health Services (BTSG) | United States | $4.246B | 32.39 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.627B | 83.06 |
| Alignment Healthcare (ALHC) | United States | $3.105B | 0.00 |
| KindlyMD (NAKA) | United States | $3.035B | 0.00 |
| Concentras Parent (CON) | United States | $2.930B | 18.58 |
| Surgery Partners (SGRY) | United States | $2.909B | 36.60 |
| Organon (OGN) | United States | $2.358B | 2.57 |
| Premier (PINC) | United States | $2.129B | 19.74 |
| Progyny (PGNY) | United States | $1.947B | 41.16 |
| Ardent Health (ARDT) | United States | $1.793B | 6.92 |
| PACS (PACS) | United States | $1.777B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.504B | 25.47 |
| Pediatrix Medical (MD) | United States | $1.483B | 9.90 |
| Teladoc Health (TDOC) | United States | $1.380B | 0.00 |
| Omada Health (OMDA) | $1.246B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.210B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.831B | 4.87 |
| AMN Healthcare Services Inc (AMN) | United States | $0.780B | 9.64 |
| CareDx (CDNA) | United States | $0.682B | 12.56 |
| Performant Healthcare (PHLT) | United States | $0.600B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.524B | 0.00 |
| Agilon Health (AGL) | United States | $0.510B | 0.00 |
| Nutex Health (NUTX) | United States | $0.500B | 7.57 |
| Sonida Senior Living (SNDA) | United States | $0.495B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.493B | 84.50 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.457B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.455B | 6.83 |
| So-Young (SY) | China | $0.433B | 0.00 |
| SBC Medicals (SBC) | United States | $0.426B | 9.32 |
| Enhabit (EHAB) | United States | $0.402B | 26.47 |
| Oncology Institute (TOI) | United States | $0.326B | 0.00 |
| LifeMD (LFMD) | United States | $0.308B | 0.00 |
| Beauty Health (SKIN) | United States | $0.257B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.227B | 0.00 |
| DocGo (DCGO) | United States | $0.161B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.149B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.115B | 0.00 |
| Biodesix (BDSX) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.025B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.021B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| ModivCare (MODV) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |